Xbrane Biopharma AB (publ)

BATS-CHIXE:XBRANS Stock Report

Market Cap: SEK 413.0m

Xbrane Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of XBRANS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,970,9890.129%
Individual Insiders32,752,0022.14%
Institutions115,943,8807.58%
General Public1,378,816,52690.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 5135.1%.

Top Shareholders

Top 25 shareholders own 11.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.7%
Nordnet AB (publ), Asset Management Arm
71,877,720SEK 19.4m14,200%0.2%
3.76%
Avanza Fonder AB
57,489,493SEK 15.5m-57.3%0.03%
1.83%
Bengt Westman
28,005,559SEK 7.6m1,040%no data
0.5%
SEB Investment Management AB
7,596,042SEK 2.1m0%no data
0.2%
Ashkan Pouya
3,120,298SEK 842.5k0%no data
0.1%
Nidda Healthcare Holding GmbH
1,570,989SEK 424.2k0%no data
0.093%
Teknik Innovation Norden Fonder AB
1,415,055SEK 382.1k0%0.01%
0.092%
Futur Pension Försäkringsaktiebolag, Asset Management Arm
1,408,825SEK 380.4k0%0.01%
0.085%
Swedbank Robur Fonder AB
1,306,172SEK 352.7k0%no data
0.074%
Håkan Stödberg
1,136,448SEK 306.8k0%no data
0.032%
Handelsbanken Asset Management
482,144SEK 130.2k0%no data
0.026%
Obadja AB
400,000SEK 108.0k0%no data
0.023%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
345,324SEK 93.2k1,500%no data
0.012%
Martin Amark
189,280SEK 51.1k0%no data
0.0076%
Siavash Bashiri
116,502SEK 31.5k0%no data
0.0067%
State Street Global Advisors, Inc.
102,277SEK 27.6k1.26%no data
0.0056%
Wbs HÜNicke VermÖGensverwaltung Gmbh
85,000SEK 23.0k0%0.01%
0.0047%
FCG Fonder AB
71,302SEK 19.2k0%no data
0.0046%
Anders Tullgren
70,484SEK 19.0k0%no data
0.0024%
Cicero Fonder AB
36,154SEK 9.7k0%no data
0.0022%
David Vikström
33,153SEK 9.0k0%no data
0.0017%
Karin Wingstrand
25,480SEK 6.9k0%no data
0.0013%
Quesada KapitalfÖRvaltning Ab
20,000SEK 5.4k0%no data
0.00098%
Anette Lindqvist
15,003SEK 4.0k0%no data
0.00098%
Peter Edman
15,000SEK 4.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/07 13:12
End of Day Share Price 2024/04/09 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xbrane Biopharma AB (publ) is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John SavinEdison Investment Research
Hans MählerNordea Markets
null nullNordea Markets